Results 321 to 330 of about 1,442,988 (353)
Some of the next articles are maybe not open access.

Resistance to Bispecific T-Cell Engagers and Bispecific Antibodies

2019
Bispecific antibodies are an emerging novel therapeutic construct used to treat a variety of cancers. These drugs utilize a small fusion protein to link two single-chain antibodies, allowing for simultaneous binding of two different epitopes. Bispecific T-cell engagers (BiTE) are a subset of bispecific antibodies that bind the target antigen on the ...
Stacy Cooper, Patrick A. Brown
openaire   +2 more sources

Immunotherapy with bispecific antibodies.

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 1995
With rare exceptions, monoclonal antibodies as therapeutic agents for cancer, have had limited anti-tumor effects. Attempts to improve the cytotoxicity of antibodies by using them as guiding agents for immune effector cells, have been developed. Numerous in vitro studies have shown that T lymphocytes can be targeted towards any target cell by using ...
openaire   +2 more sources

The present and future of bispecific antibodies for cancer therapy.

Nature reviews. Drug discovery
Christian Klein   +3 more
semanticscholar   +1 more source

Bispecific antibodies in myeloma

Hématologie, 2021
Sophie Le Grand, Aurore Perrot
openaire   +1 more source

Bispecific and multispecific antibodies in oncology: opportunities and challenges.

Nature Reviews Clinical Oncology
M. Goebeler, Gernot Stuhler, Ralf Bargou
semanticscholar   +1 more source

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Nature, 2022
Yunlong Cao, Jing Wang, Fanchong Jian
exaly  

The renaissance of chemically generated bispecific antibodies

Nature Reviews Chemistry, 2021
Peter A. Szijj, V. Chudasama
semanticscholar   +1 more source

Bispecific antibodies: a mechanistic review of the pipeline

Nature reviews. Drug discovery, 2019
A. Labrijn   +3 more
semanticscholar   +1 more source

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Nature, 2021
Jianliang Xu   +2 more
exaly  

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Nature, 2022
Yunlong Cao, Fanchong Jian, Shuo Du
exaly  

Home - About - Disclaimer - Privacy